Article Versions Notes

Guo Y, Meng J-R, Liu J-Z, Xu T, Zheng Z-Y, Jiang Z-H, Bai L-P. Synthesis and Biological Evaluation of Honokiol Derivatives Bearing 3-((5-phenyl-1,3,4-oxadiazol-2-yl)methyl)oxazol-2(3H)-ones as Potential Viral Entry Inhibitors against SARS-CoV-2. Pharmaceuticals. 2021; 14(9):885. https://doi.org/10.3390/ph14090885

Guo, Yong, Jie-Ru Meng, Jia-Zheng Liu, Ting Xu, Zhi-Yuan Zheng, Zhi-Hong Jiang, and Li-Ping Bai. 2021. "Synthesis and Biological Evaluation of Honokiol Derivatives Bearing 3-((5-phenyl-1,3,4-oxadiazol-2-yl)methyl)oxazol-2(3H)-ones as Potential Viral Entry Inhibitors against SARS-CoV-2" Pharmaceuticals 14, no. 9: 885. https://doi.org/10.3390/ph14090885

Guo, Y., Meng, J.-R., Liu, J.-Z., Xu, T., Zheng, Z.-Y., Jiang, Z.-H., & Bai, L.-P. (2021). Synthesis and Biological Evaluation of Honokiol Derivatives Bearing 3-((5-phenyl-1,3,4-oxadiazol-2-yl)methyl)oxazol-2(3H)-ones as Potential Viral Entry Inhibitors against SARS-CoV-2. Pharmaceuticals, 14(9), 885. https://doi.org/10.3390/ph14090885